Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Before OpenAI launched its new AI agent, Dots, on Tuesday, Elon Musk's xAI had already acq...
Researchers at Northeastern University found vehicles and their companion apps regularly s...
New sculpture depicts AI leaders escaping a sinking ship.
EliseAI raises $350M, doubles valuation in a year.
The company says it won't draw on the new debt facilities this year, as it has already pla...